Back to Search
Start Over
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma.
- Source :
-
Annals of Hematology . Dec2021, Vol. 100 Issue 12, p3057-3060. 4p. - Publication Year :
- 2021
-
Abstract
- Four patients had extramedullary disease, including plasma cell leukemia with leptomeningeal involvement, and 2/4 patients had a PR. Dear Editor, Multiple myeloma (MM) is a plasma cell dyscrasia that eventually becomes refractory to all available therapies. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 09395555
- Volume :
- 100
- Issue :
- 12
- Database :
- Academic Search Index
- Journal :
- Annals of Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 153584512
- Full Text :
- https://doi.org/10.1007/s00277-020-04293-y